These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 6900485)

  • 1. Drugs in current use: calcitriol.
    Aust Nurses J; 1980 Feb; 9(7):27-8. PubMed ID: 6900485
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcifediol (25-hydroxyvitamin D3) in the treatment of uremic bone disease.
    Teitelbaum SL
    Ann Intern Med; 1981 Mar; 94(3):404-5. PubMed ID: 6894359
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcitriol.
    Med Lett Drugs Ther; 1979 Jun; 21(12):50-1. PubMed ID: 449839
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypoparathyroidism and pregnancy. Treatment with calcitriol.
    Sadeghi-Nejad A; Wolfsdorf JI; Senior B
    JAMA; 1980 Jan; 243(3):254-5. PubMed ID: 7350374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcemia during long-term treatment with 1,25-dihydroxyvitamin D3 in hypoparathyroidism.
    Bell NH; Epstein S; Stern PH
    N Engl J Med; 1979 Nov; 301(21):1183-4. PubMed ID: 492291
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized double blind study of 1, 25(OH)2D3 in dialysis patients.
    Maxwell DR; Benjamin DM; Donahay SL; Allen MK; Hamburger RJ; Luft FC; Kleit SA
    Proc Clin Dial Transplant Forum; 1977; 7():166-9. PubMed ID: 210446
    [No Abstract]   [Full Text] [Related]  

  • 7. Is calcitriol [1,25(OH)2D3] harmful to renal function?
    Massry SG; Goldstein DA
    JAMA; 1979 Oct; 242(17):1875-6. PubMed ID: 480619
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypercalcemia and increases in serum hormone value during prolonged administration of 1alpha,25-dihydroxyvitamin D.
    Bell NH; Stern PH
    N Engl J Med; 1978 Jun; 298(22):1241-3. PubMed ID: 651964
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcitriol in disorders of bone and calcium metabolism.
    Riggs BL
    Clin Ther; 1980; 3(1):33-9. PubMed ID: 6893296
    [No Abstract]   [Full Text] [Related]  

  • 10. Does uremic bone disease warrant early treatment with calcitriol?
    Chesney RW
    Arch Intern Med; 1980 Aug; 140(8):1016-7. PubMed ID: 6893117
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: Idiosyncratic reaction to 25-hydroxylated Vitamin D3.
    Gegick CG; Danowski TS; De Luca HF; Holick MF
    Ann Intern Med; 1974 Mar; 80(3):416-7. PubMed ID: 4816190
    [No Abstract]   [Full Text] [Related]  

  • 12. 1,25-dihydroxy-vitamin D3: a new treatment for hypoparathyroidism.
    Glatthaar C; Smith R; Espiner EA; Donald RA; Hinton D
    N Z Med J; 1980 Oct; 92(669):267-71. PubMed ID: 6934421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-term therapy with calcitriol in patients with moderate renal failure.
    Healy MD; Malluche HH; Goldstein DA; Singer FR; Massry SG
    Arch Intern Med; 1980 Aug; 140(8):1030-3. PubMed ID: 6893118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcium phosphate metabolism during therapy with 1,25-dihydroxycholecalciferol [1,25 DHCC (Ro 21/5535)] in patients with advanced kidney insufficiency].
    Schulz W; Spiegel P; Gessler U; Delling G
    Verh Dtsch Ges Inn Med; 1978; (84):1297-301. PubMed ID: 741953
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of 5,6-trans-25-OH-cholecalciferol in patients needing dialysis with florid renal osteopathy: therapeutic management and treatment results].
    Cremer W; Graben N; Merguet P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1307-10. PubMed ID: 611841
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: 1,25-Dihydroxyvitamin D3 and pseudohypoparathyroidism.
    Sinha TK; Bell NH
    N Engl J Med; 1976 Mar; 294(11):612. PubMed ID: 1246249
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of metabolites and analogues of vitamin D in prospective renal transplant recipients.
    Cundy T; Kanis JA; Fraher L; Clemens TL; O'Riordan JL
    Clin Nephrol; 1981 May; 15(5):240-5. PubMed ID: 7018772
    [No Abstract]   [Full Text] [Related]  

  • 18. Failure of 1,25-DHCC in hypoparathyroidism.
    Bongiovanni AM
    N Engl J Med; 1978 Mar; 298(10):573. PubMed ID: 625318
    [No Abstract]   [Full Text] [Related]  

  • 19. New developments in pharmacology of vitamin D.
    Med Lett Drugs Ther; 1974 Feb; 16(3):15-6. PubMed ID: 4358446
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recommended for use in various bone diseases: therapy with a vitamin D metabolite].
    MMW Munch Med Wochenschr; 1979 Aug; 121(34):1062. PubMed ID: 114759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.